Dethrombosis of the lower extremity arteries using the power-pulse spray technique in patients with recent onset thrombotic occlusions: Result of the DETHROMBOSIS registry

Journal of Endovascular Therapy

Volumn 15, Issue 5, 2008, Pages 570-579

  Shammas, Nicolas W ^a   Dippel, Eric J ^a   Shammas, Gail ^a   Gayton, Laura ^a   Coiner, Denise ^a   Jerin, Mike ^a  

^a MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; HIRULOG; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ANGIOGRAPHY; ARTERY EMBOLISM; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEATH; DISEASE DURATION; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; KIDNEY FAILURE; LEG AMPUTATION; LEG ISCHEMIA; LEG REVASCULARIZATION; LOADING DRUG DOSE; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RHEOLYTIC THROMBECTOMY; STROKE; TREATMENT OUTCOME; VASCULAR ACCESS;

ACUTE DISEASE; AGED; ALGORITHMS; CHRONIC DISEASE; FEASIBILITY STUDIES; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; PROSPECTIVE STUDIES; REGISTRIES; THROMBECTOMY; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 56349098257     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/08-2453.1     Document Type: Article

References (27)

1. Shammas NW, Dippel EJ. Evidence-based management of peripheral vascular disease. Curr Atheroscler Rep. 2005;7:358-863.
2. Shammas NW. Dethrombosis of the lower extremities. Pharmacologic and mechanical techniques. Vasc Dis Manage. 2006;May/June: 235-239.
3. Ouriel K, Shortell CK, DeWeese JA, et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg. 1994; 19:1021-1030.
4. Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J Vasc Surg. 1996;23: 64-73.
5. Weaver FA, Comerota AJ, Youngblood M, et al. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg. 1996;24:513-521.
6. Ansel GM, George BS, Botti CF, et al. Rheolytic thrombectomy in the management of limb ischemia: 30-day results from a multicenter registry. J Endovasc Ther. 2002;9:395-402.
7. Allie DE, Hebert CJ, Lirtzman MD, et al. Novel simultaneous combination chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb ischemia: the power-pulse spray technique. Catheter Cardiovasc Interv. 2004;63: 512-522.
8. Rossi E, Biasucci LM, Citterio F, et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation. 2002;105:800-803.
9. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481-2485.
10. Gorter PM, Olijhoek JK, van der Graaf Y, et al. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004;173:363-369.
11. Shammas NW, Dippel EJ, Coiner D, et al. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther. 2008;15: 270-276.
12. Kasirajan K, Haskal ZJ, Ouriel K. The use of mechanical thrombectomy devices in the management of acute peripheral arterial occlusive disease. J Vasc Interv Radiol. 2001;12:405-411.
13. Wholey MH, Maynar MA, Wholey MH, et al. Comparison of thrombolytic therapy of lower-extremity acute, subacute, and chronic arterial occlusions. Cathet Cardiovasc Diagn. 1998;44: 159-169.
14. Siablis D, Karnabatidis D, Katsanos K, et al. Outflow protection filters during percutaneous recanalization of lower extremities' arterial occlusions: a pilot study. Eur J Radiol. 2005;55: 243-249.
15. Suri R, Wholey MH, Postoak D, et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv. 2006; 67:417-422.
16. Karnabatidis D, Katsanos K, Kagadis GC, et al. Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovasc Ther. 2006;13:269-280.
17. Shammas NW. Embolization in lower extremity percutaneous interventions: recommendations and strategies for embolic filter protection use. Vasc Dis Manage. 2008;5: 22-26.
18. Shammas NW. Bivalirudin: pharmacology and clinical applications. Cardiovasc Drug Rev. 2005;23:345-360.
19. Lincoff AM, Bittl JA, Kleiman NS, et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol. 2004;93:1092-1096.
20. Allie DE, Hebert CJ, Lirtzman MD, et al. A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome. J Invasive Cardiol. 2005;17:427-432.
21. French JK, Edmond JJ, Gao W, et al. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction. Am J Cardiovasc Drugs. 2004;4:107-115.
22. Lincoff AM, Bittl JA, Harrington RA. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa during percutaneous coronary intervention; the REPLACE-2 randomized trial. JAMA. 2003;289:853-863.
23. Allie DE, Lirtzman MD, Wyatt CH, et al. Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions. J Invasive Cardiol. 2003;15:334-342.
24. Shammas NW, Lemke JH, Dippel EJ, et al. Bivalirudin in peripheral vascular interventions: a single center experience. J Invasive Cardiol. 2003;15:401-404.
25. Allie DE, Hall P, Shammas NW, et al. The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE): in-hospital and 30-day results. J Invasive Cardiol. 2004;16:651-656.
26. Duda SH, Tepe G, Luz O, et al. Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone - a randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis. Radiology. 2001;221:689-696.
27. Allie DE, Hebert CJ, Lirtzman MD, et al. Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/ IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience. J Endovasc Ther. 2004;11:427-435.